Treating diabetes with combination of phosphodiesterase 5 inhibitors and hydroxychloroquine—a possible prevention strategy for COVID-19?

Type 2 diabetes (T2D) is one of the major risk factors for developing cardiovascular disease and the resultant devastating morbidity and mortality. The key features of T2D are hyperglycemia, hyperlipidemia, insulin resistance, and impaired insulin secretion. Patients with diabetes and myocardial inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Kukreja, Rakesh C., Wang, Rui, Koka, Saisudha, Das, Anindita, Samidurai, Arun, Xi, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421626/
https://www.ncbi.nlm.nih.gov/pubmed/36036333
http://dx.doi.org/10.1007/s11010-022-04520-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421626/
https://www.ncbi.nlm.nih.gov/pubmed/36036333
http://dx.doi.org/10.1007/s11010-022-04520-2

Ejemplares similares